U.S. Stock News

A new multi-year managed services agreement in Chile between Millicom International Cellular (TIGO) and Amdocs is drawing fresh attention to the stock. The deal centers on advanced BSS and OSS platforms with AI-driven management. Millicom International Cellular’s latest Chile agreement comes after a period of strong share price momentum, with a 90 day share price return of 9.4% and a year to date share price return of 65.13%. The 1 year total shareholder return of 111.46% and very large 3...

Washington’s potential new 7.5% tariff on Chinese goods, and the risk of a forceful response from Beijing, is reshaping how companies think about factories, freight routes and customs paperwork. Supply chains built on low cost imports now face higher bills and fresh uncertainty, which can create new winners and losers. This article walks through 3 stocks from our North American Nearshoring and Trade-Compliance Enablers screener that appear closely tied to these shifting trade currents. The 3...

Graphic Packaging Holding (GPK) is back in focus after a stockholder filed an August 2026 derivative lawsuit that mirrors a similar June action, alleging securities law violations and fiduciary breaches by current and former leaders. Against this backdrop, Graphic Packaging Holding’s share price has been under pressure over 2026, with a year to date share price return declining 23.7% and a 1 year total shareholder return falling 46.3%. The stock has recently shown a 90 day share price return...

Prestige Consumer Healthcare recently initiated a voluntary, FDA-classified Class II recall of 39,060 CLEAR EYES Maximum Itchy Eye Relief 15mL bottles across the US, after regulators cited a lack of assurance of sterility and potential contamination in lot 2552A, expiring September 30, 2027. This targeted recall in a core eye-care product raises questions about product quality controls and potential operational disruption for a brand that relies heavily on consumer trust. We’ll now examine...

In August 2026, Biohaven Ltd. announced a global licensing and collaboration agreement giving SK Biopharmaceuticals exclusive worldwide rights to its Kv7 ion channel platform, including opakalim, with up to US$795 million in upfront and milestone payments plus tiered royalties. A key feature of the deal is that SK Biopharmaceuticals will fund future Kv7 program costs and assume up to US$245 million in existing milestone and royalty obligations, materially easing Biohaven’s development...

Trulieve Cannabis Corp. recently closed its August 2025 shelf registration, issuing 10,000,000 subordinate voting shares worth US$55.5 million in an ESOP-related offering. This ESOP-focused issuance expands the company’s equity base while deepening employee ownership, which can influence future capital flexibility and workforce alignment. We’ll now explore how this ESOP-related share issuance may affect Trulieve’s investment narrative around growth, margins and capital deployment. Invest in...

Neogen (NEOG) has drawn investor attention after its recent share price move, with the stock up about 24% over the past month and roughly 30% over the past 3 months. Zooming out, Neogen’s 1 year total shareholder return of about 103% and year to date share price return of nearly 67% point to strong recent momentum. However, the 3 year and 5 year total shareholder returns, down roughly 50% and 74% respectively, highlight how this rebound follows a much weaker longer term record. Capture...

We wouldn't blame Comfort Systems USA, Inc. ( NYSE:FIX ) shareholders if they were a little worried about the fact that...

The recent 21% drop in Adagio Medical Holdings, Inc.'s ( NASDAQ:ADGM ) stock could come as a blow to insiders who...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Moelis hire puts fresh focus on restructuring advisory depth Moelis (MC) has drawn investor attention after appointing Russell Mason as Managing Director in its Capital Structure Advisory Group, highlighting a renewed senior focus on complex restructuring and distressed M&A assignments. At a share price of US$68.40, Moelis has seen a 4.83% one-month share price return, while the year-to-date share price is down 3.96%. Over a longer horizon, total shareholder return of 61.90% over three years...

Sportradar Group (NasdaqGS:SRAD) is back in focus after announcing an expanded agreement with Polymarket that now covers premium data, streaming, and integrity services across more than 20 global sports leagues and competitions. The stock has been under pressure despite this series of new agreements. Sportradar Group’s share price return is down 44.51% year to date and the 1 year total shareholder return is down 58.18%. However, the 3 year total shareholder return of 12.42% points to stronger...

La-Z-Boy (LZB) is in focus after first quarter earnings showed sales of US$475.69 million and a net loss of US$2.29 million, along with softer guidance and pressure on profitability expectations. Over the past month La-Z-Boy's share price has fallen about 20%, and is down around 13% over 90 days, with the softer first quarter, cautious guidance and comments about margin pressure reinforcing that weaker short term momentum, even though 3 and 5 year total shareholder returns remain...

Recent performance snapshot for Etsy stock Etsy (ETSY) has drawn fresh attention after a recent move in its share price, with the stock closing at US$83.59 on 27 August 2026. Investors are weighing this level against the company’s latest return profile. Over the past day the stock gained 0.8%. The past week shows a 3.2% rise. Over the past month the share price declined 2.3%, while the past 3 months show a 23.1% gain and the 1 year total return is 57.7%. For Etsy, the recent 3 month share...

Silgan Holdings (SLGN) drew investor attention after reporting second quarter 2026 adjusted earnings of $0.98 per share, topping estimates while reaffirming full year earnings, free cash flow, and capital expenditure guidance. Silgan Holdings' latest update comes after a mixed year in the market, with the stock currently at $42.10 and a 90 day share price return of 12.09% contrasted with a 1 year total shareholder return that declined 8.47%. This suggests that recent momentum has improved,...

Alexandria Real Estate Equities (ARE) has drawn fresh attention after recent price moves left the stock trading around $51.57, with returns mixed over the past month and past 3 months for this life science focused REIT. Over the past year, Alexandria Real Estate Equities has seen its share price slip in the short term, with a 7 day share price return down 3.59% and a 30 day share price return down 4.09%. The 1 year total shareholder return is down 33.63%, pointing to fading momentum despite a...

With central banks flagging that inflation remains a risk, interest rates may stay higher for longer. That keeps bond yields in focus and raises the bar for income investments. Reliable dividend streams start to look more attractive when cash needs a competitive reason to stay put. This article walks through three stocks from the Dividend Powerhouses screener that offer 3%+ yields, described as well covered and growing, for investors who want income with discipline. The three stocks in this...

Recent commentary on rising U.S. energy exports has put Kinder Morgan (KMI) in focus, with its pipeline and terminal network seeing higher utilization as international demand and Permian Basin production support export driven volumes. At a share price of US$31.56, Kinder Morgan has seen steady positive share price momentum over the year, with a year to date share price return of 13.89% and a 1 year total shareholder return of 21.67%. This hints that investors are responding to export related...

Futu Holdings has delivered a 103.7% gain over the past three years, yet current valuation checks suggest the stock may still trade below a conservative view of its worth. Both market multiples and an Excess Returns intrinsic value estimate point to upside relative to the current share price, which raises questions for investors about how much of the recent business momentum is already reflected. The 103.7% return over three years shows that long term holders have already seen strong gains,...

Kingsoft Cloud Holdings Limited reported half-year 2026 results, with revenue rising to CNY 5,775.7 million from CNY 4,319.2 million and net loss narrowing to CNY 436.9 million from CNY 771.39 million, while basic loss per share from continuing operations improved to CNY 1.5 from CNY 3 a year earlier. The combination of faster revenue growth and a smaller loss suggests improving operating efficiency, which may influence how investors assess Kingsoft Cloud’s path toward financial...

Earlier this week, Medpace Holdings reported another quarter of solid operational execution, highlighted by average organic revenue growth of 17.2% year over year and a marked improvement in free cash flow margins over recent years. The more cautious analyst forecast of just 4.1% revenue growth over the next 12 months suggests that, despite the strong recent performance, investors are now weighing emerging demand challenges and a possible slowdown in project momentum. We’ll now examine how...

SuperCom Ltd. ( NASDAQ:SPCB ), might not be a large cap stock, but it received a lot of attention from a substantial...

CME Group has delivered a strong 80.5% return over the past 5 years, yet current valuation checks suggest the stock is trading at a premium to what its fundamentals imply. Both the Excess Returns intrinsic value estimate and market multiple comparisons point to the shares looking expensive rather than like a clear bargain right now. The 80.5% 5 year return highlights that CME Group has already rewarded long term holders, which can limit how much additional upside is priced in today. Growth...

Earlier this week, Acadia Healthcare reported adjusted second-quarter earnings that exceeded estimates and raised its 2026 outlook for revenue, adjusted EBITDA, operating cash flow and EPS, supported by stronger patient admissions and demand in key service lines. However, the company’s improved guidance comes alongside a history of weaker admissions, less profitable incremental revenue and annual EPS declines, highlighting an ongoing tension between growth ambitions and profitability. Next,...